Breast Cancer Clinical Trial
— e-CUIDACHEMOOfficial title:
e-CUIDACHEMO: Telerehabilitation During Chemotherapy in Breast Cancer Patients
| Verified date | July 2017 |
| Source | Universidad de Granada |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Patients with breast cancer undergo a series of psiclofisicas alterations during cancer
treatment, chemotherapy phase being one of the more aggressive ete effect. These changes
reduce the quality of life and result in a loss of physical health-related condition. Studies
have shown that the practice of physical exercise and rehabilitation strategies enhance or
attenuate the impact of chemotherapy on quality of life of patients. At present,
technological development from telerehabilitación systems is a promising strategy that
enables fast and efficient communication between health professionals and patients,
especially at this stage of the disease where the patient may encounter difficulties in
matching measures improving their lifestyle with aggressive medical treatment.
To carry out this study a controlled study masked, parallel-group done were conducted usual
care control group and an intervention based on a web system telerehabilitación to improve
the physical condition associated with health and performed quality of life.
| Status | Completed |
| Enrollment | 60 |
| Est. completion date | August 2016 |
| Est. primary completion date | June 2015 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 25 Years to 80 Years |
| Eligibility |
Inclusion Criteria: - Diagnosis of stage I, II, or IIIA breast cancer - Medical clearance of participation - Access to the Internet - Basic ability to use a computer or living with someone who has this ability - In chemotherapy treatment at present moment; - Have interest in improving lifestyle: fitness level - Have signed informed consent Exclusion Criteria: - Chronic disease or orthopedic issues that would interfere with ability to participate in a physical activity program; |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Faculty of Health Sciences. University of Granada | Granada |
| Lead Sponsor | Collaborator |
|---|---|
| Universidad de Granada | Health Service of Andalucia |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Cardiorespiratory capacity | Distance in meters in 6 minutes walking test | 1 day | |
| Secondary | Abdominal endurance strength | Abdominal resistance using curl-up test | 1 day | |
| Secondary | Lumbar extensor endurance strength | Lumbar extensor strength using dynamometer | 1 day | |
| Secondary | Handgrip endurance strength | Handgrip endurance using isometric dynamometer | 1 day | |
| Secondary | Cancer related fatigue | Piper Fatigue Scale | 2 days | |
| Secondary | Cancer related pain | Brief Pain Inventory | 2 days | |
| Secondary | Cancer related quality of life | EORTC Quality of life questionaire Core and Br23 | 2 days |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |